|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US10869845||ENDO VENTURES||Ephedrine compositions and methods|| |
(16 years from now)
Ephedrine Sulfate is owned by Endo Ventures.
Ephedrine Sulfate contains Ephedrine Sulfate.
Ephedrine Sulfate has a total of 1 drug patent out of which 0 drug patents have expired.
Ephedrine Sulfate was authorised for market use on 16 October, 2020.
Ephedrine Sulfate is available in solution;intravenous dosage forms.
The generics of Ephedrine Sulfate are possible to be released after 22 January, 2040.
Market Authorisation Date: 16 October, 2020